These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30472913)

  • 1. Brinzolamide-loaded nanoemulsions: ex vivo transcorneal permeation, cell viability and ocular irritation tests.
    Mahboobian MM; Seyfoddin A; Aboofazeli R; Foroutan SM; Rupenthal ID
    Pharm Dev Technol; 2019 Jun; 24(5):600-606. PubMed ID: 30472913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acyclovir-Loaded Nanoemulsions: Preparation, Characterization and Irritancy Studies for Ophthalmic Delivery.
    Mohammadi M; Elahimehr Z; Mahboobian MM
    Curr Eye Res; 2021 Nov; 46(11):1646-1652. PubMed ID: 33979552
    [No Abstract]   [Full Text] [Related]  

  • 3. Besifloxacin-loaded ocular nanoemulsions: design, formulation and efficacy evaluation.
    Kassaee SN; Mahboobian MM
    Drug Deliv Transl Res; 2022 Jan; 12(1):229-239. PubMed ID: 33575973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liposomes as a Novel Ocular Delivery System for Brinzolamide: In Vitro and In Vivo Studies.
    Li H; Liu Y; Zhang Y; Fang D; Xu B; Zhang L; Chen T; Ren K; Nie Y; Yao S; Song X
    AAPS PharmSciTech; 2016 Jun; 17(3):710-7. PubMed ID: 26335415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TPGS modified nanoliposomes as an effective ocular delivery system to treat glaucoma.
    Jin Q; Li H; Jin Z; Huang L; Wang F; Zhou Y; Liu Y; Jiang C; Oswald J; Wu J; Song X
    Int J Pharm; 2018 Dec; 553(1-2):21-28. PubMed ID: 30316795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring Penetration Ability of Carbonic Anhydrase Inhibitor-Loaded Ultradeformable Bilosome for Effective Ocular Application.
    Nair VS; Srivastava V; Bhavana V; Yadav R; Rajana N; Singh SB; Mehra NK
    AAPS PharmSciTech; 2023 Jul; 24(6):157. PubMed ID: 37470885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ophthalmic delivery of brinzolamide by liquid crystalline nanoparticles: in vitro and in vivo evaluation.
    Wu W; Li J; Wu L; Wang B; Wang Z; Xu Q; Xin H
    AAPS PharmSciTech; 2013 Sep; 14(3):1063-71. PubMed ID: 23813437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of the Bovine Corneal Opacity and Permeability (BCOP) assay as an in vitro alternative to the Draize rabbit eye irritation test.
    Verstraelen S; Jacobs A; De Wever B; Vanparys P
    Toxicol In Vitro; 2013 Jun; 27(4):1298-311. PubMed ID: 23501624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of the ocular irritation potential of various alkyl polyglucoside surfactants.
    Cho SA; Han JH; An S; Lee KH; Park JH; Kim HK; Lee TR
    Cutan Ocul Toxicol; 2010 Mar; 29(1):50-6. PubMed ID: 20039788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brinzolamide nanocrystal formulations for ophthalmic delivery: reduction of elevated intraocular pressure in vivo.
    Tuomela A; Liu P; Puranen J; Rönkkö S; Laaksonen T; Kalesnykas G; Oksala O; Ilkka J; Laru J; Järvinen K; Hirvonen J; Peltonen L
    Int J Pharm; 2014 Jun; 467(1-2):34-41. PubMed ID: 24680962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conjunctival and corneal tolerability assessment of ocular naltrexone niosomes and their ingredients on the hen's egg chorioallantoic membrane and excised bovine cornea models.
    Abdelkader H; Ismail S; Hussein A; Wu Z; Al-Kassas R; Alany RG
    Int J Pharm; 2012 Aug; 432(1-2):1-10. PubMed ID: 22575752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ocular microemulsion of brinzolamide: Formulation, physicochemical characterization, and in vitro irritation studies based on EpiOcular™ eye irritation assay.
    Siafaka PI; Çağlar EŞ; Sipahi H; Charehsaz M; Aydın A; Üstündağ Okur N
    Pharm Dev Technol; 2021 Sep; 26(7):765-778. PubMed ID: 34154503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the Ocular Tolerance of Three Tacrolimus Topical Pharmaceutical Preparations by Bovine Corneal Opacity and Permeability Test.
    Pastor-Clerigues A; Serrano A; Milara J; Marti-Bonmati E; Lopez-Perez FJ; Garcia-Montanes S; Sanfeliu J; Saval-Victoria AC; Cortijo J
    Curr Eye Res; 2016 Jul; 41(7):890-6. PubMed ID: 26554729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Ocular Irritation and Bioavailability of Voriconazole Loaded Microemulsion.
    Kumar R; Sinha VR
    Curr Drug Deliv; 2017; 14(5):718-724. PubMed ID: 27538459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revamping the corneal permeability and antiglaucoma therapeutic potential of brinzolamide using transniosomes: optimization,
    Patil RK; Srivastava V; Bhawale R; Tryphena KP; Khatri DK; Doijad N; Mehra NK
    Nanomedicine (Lond); 2024; 19(11):947-964. PubMed ID: 38483291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and development of a novel pH triggered nanoemulsified in-situ ophthalmic gel of fluconazole: ex-vivo transcorneal permeation, corneal toxicity and irritation testing.
    Pathak MK; Chhabra G; Pathak K
    Drug Dev Ind Pharm; 2013 May; 39(5):780-90. PubMed ID: 22873799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poloxamer-based thermoresponsive ketorolac tromethamine in situ gel preparations: Design, characterisation, toxicity and transcorneal permeation studies.
    M A Fathalla Z; Vangala A; Longman M; Khaled KA; Hussein AK; El-Garhy OH; Alany RG
    Eur J Pharm Biopharm; 2017 May; 114():119-134. PubMed ID: 28126392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eye irritation of low-irritant cosmetic formulations: correlation of in vitro results with clinical data and product composition.
    Debbasch C; Ebenhahn C; Dami N; Pericoi M; Van den Berghe C; Cottin M; Nohynek GJ
    Food Chem Toxicol; 2005 Jan; 43(1):155-65. PubMed ID: 15582208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid Nanocarrier: an Efficient Approach Towards Ocular Delivery of Hydrophilic Drug (Valacyclovir).
    Kumar R; Sinha VR
    AAPS PharmSciTech; 2017 Apr; 18(3):884-894. PubMed ID: 27368921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of loteprednol etabonate-loaded cationic nanoemulsified in-situ ophthalmic gel for sustained delivery and enhanced ocular bioavailability.
    Patel N; Nakrani H; Raval M; Sheth N
    Drug Deliv; 2016 Nov; 23(9):3712-3723. PubMed ID: 27689408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.